Literature DB >> 22377646

Risk factors associated with vestibular nerve schwannomas.

Ana Paula Corona1, Silvia Ferrite, Marcia da Silva Lopes, Marco Antônio Vasconcelos Rêgo.   

Abstract

INTRODUCTION: Vestibular nerve schwannoma is a benign tumor that originates in the sheath of Schwann of the eighth cranial nerve. It is considered one of the most common benign intracranial tumors, and its cause is unclear.
OBJECTIVE: To identify the risk factors associated with vestibular nerve schwannomas.
METHODS: A hospital-based exploratory case-control study was conducted between 2006 and 2010 in 2 municipalities in the northeast region of Brazil. We included individuals with unilateral vestibular nerve schwannomas confirmed by imaging. The controls, selected from the same institutions as the cases, exhibited unilateral hearing loss or tinnitus and had undergone investigatory examinations similar to those of the cases, but the presence of tumor had been excluded. A pretested structured questionnaire, administered by trained interviewers who were blind to the condition of the individual being interviewed, was used to obtain sociodemographic data and data on potential risk factor exposure. We performed a multivariate analysis using unconditional logistic regression.
RESULTS: A total of 44 patients with vestibular nerve schwannomas and 104 controls participated in the study. A history of chicken pox (odds ratio, 6.59; 95% confidence interval, 2.07-20.9) and the exposure to more than 1 cranial x-ray procedure (odds ratio, 4.55; 95% confidence interval, 1.10-19.2) were identified as potential risk factors.
CONCLUSION: This exploratory study brings new hypotheses to be tested and thus works toward clarifying the causes and mechanisms involved in the cause and development of vestibular nerve schwannoma.

Entities:  

Mesh:

Year:  2012        PMID: 22377646     DOI: 10.1097/MAO.0b013e3182487fee

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  6 in total

1.  Vestibular schwannoma and pituitary adenoma in the same patient: coincidence or novel clinical association?

Authors:  Matthew L Carlson; Neil S Patel; Amy E Glasgow; Elizabeth B Habermann; Brandon R Grossardt; Michael J Link
Journal:  J Neurooncol       Date:  2016-02-22       Impact factor: 4.130

2.  Epidemiology Of Vestibular Schwannomas - Prospective 40-Year Data From An Unselected National Cohort.

Authors:  Martin Reznitsky; Mette Marie Babiel Schmidt Petersen; Niels West; Sven-Eric Stangerup; Per Cayé-Thomasen
Journal:  Clin Epidemiol       Date:  2019-11-08       Impact factor: 4.790

3.  Diagnostic radiological examinations and risk of intracranial tumours in adults-findings from the Interphone Study.

Authors:  Anssi Auvinen; Elisabeth Cardis; Maria Blettner; Monika Moissonnier; Siegal Sadetzki; Graham Giles; Christoffer Johansen; Anthony Swerdlow; Angus Cook; Sarah Fleming; Gabriele Berg-Beckhoff; Ivano Iavarone; Marie-Elise Parent; Alistair Woodward; Tore Tynes; Mary McBride; Dan Krewski; Maria Feychting; Toru Takebayashi; Bruce Armstrong; Martine Hours; Jack Siemiatycki; Susanna Lagorio; Signe Benzon Larsen; Minouk Schoemaker; Lars Klaeboe; Stefan Lönn; Joachim Schüz
Journal:  Int J Epidemiol       Date:  2022-05-09       Impact factor: 9.685

4.  Pooled analysis of case-control studies on acoustic neuroma diagnosed 1997-2003 and 2007-2009 and use of mobile and cordless phones.

Authors:  Lennart Hardell; Michael Carlberg; Fredrik Söderqvist; Kjell Hansson Mild
Journal:  Int J Oncol       Date:  2013-07-22       Impact factor: 5.650

Review 5.  Risk Factors of Acoustic Neuroma: Systematic Review and Meta-Analysis.

Authors:  Mantao Chen; Zuoxu Fan; Xiujue Zheng; Fei Cao; Liang Wang
Journal:  Yonsei Med J       Date:  2016-05       Impact factor: 2.759

6.  Cellular Phone Use and Risk of Tumors: Systematic Review and Meta-Analysis.

Authors:  Yoon-Jung Choi; Joel M Moskowitz; Seung-Kwon Myung; Yi-Ryoung Lee; Yun-Chul Hong
Journal:  Int J Environ Res Public Health       Date:  2020-11-02       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.